Pharmaceutical Tablet Composition Comprising Eltrombopag Olamine

Patent No. EP3395331 (titled "Pharmaceutical Tablet Composition Comprising Eltrombopag Olamine") was filed by Alfred E Tiefenbacher on Jul 14, 2017. The application was issued on Aug 21, 2019.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

Company	Opposition Date	Representative
BULLE DR	May 20, 2020	KUTZENBERGER

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

Date
Description

Get instant alerts for new documents

Dec 3, 2021
Communication to the parties concerning the termination of the opposition proceedings (opponent)
Dec 3, 2021
Communication to the parties concerning the termination of the opposition proceedings (proprietor)
Nov 30, 2021
Termination of the opposition proceedings with revocation of patent
Aug 23, 2021
Advice of delivery
Aug 19, 2021
Advice of delivery
Aug 19, 2021
Decision revoking the European patent
Aug 19, 2021
Decision revoking the European patent
Aug 19, 2021
Notification concerning the date of oral proceedings
Aug 19, 2021
Notification concerning the date of oral proceedings
Aug 19, 2021
Transmittal of decision / summons - opposition
Aug 19, 2021
Transmittal of decision / summons - opposition
Aug 13, 2021
(Electronic) Receipt
Aug 13, 2021
Letter accompanying subsequently filed items
Aug 13, 2021
Request for revocation of patent
Aug 12, 2021
(Electronic) Receipt
Aug 12, 2021
Letter accompanying subsequently filed items
Aug 6, 2021
Notification concerning the date of oral proceedings
Aug 6, 2021
Notification concerning the date of oral proceedings
Jul 6, 2021
Brief communication - Opposition proceedings
Jul 1, 2021
(Electronic) Receipt
Jul 1, 2021
Letter accompanying subsequently filed items
Jul 1, 2021
Request for interpreters during oral proceedings
Mar 25, 2021
Annex to the communication
Mar 25, 2021
Notification concerning the date of oral proceedings
Mar 25, 2021
Notification concerning the date of oral proceedings
Mar 17, 2021
(Electronic) Receipt
Mar 17, 2021
Advice of delivery
Mar 17, 2021
Letter accompanying subsequently filed items
Mar 17, 2021
Oral proceedings: Request for postponement
Mar 16, 2021
Annex to the communication - opposition
Mar 16, 2021
Summons to attend oral proceedings
Mar 16, 2021
Summons to attend oral proceedings
Mar 16, 2021
Transmittal of decision / summons - opposition
Mar 16, 2021
Transmittal of decision / summons - opposition
Mar 3, 2021
Information about the result of oral proceedings
Jan 18, 2021
Communication of amended entries concerning the representative
Dec 28, 2020
Request concerning the applicant/representative
Dec 28, 2020
Submission concerning change of applicant's representative
Dec 28, 2020
Submission concerning change of applicant's representative
Oct 30, 2020
Brief communication - Opposition proceedings
Oct 27, 2020
(Electronic) Receipt
Oct 27, 2020
Auxiliary request during Opposition procedure
Oct 27, 2020
Auxiliary request during Opposition procedure - 01
Oct 27, 2020
Citation in opposition procedure - 023
Oct 27, 2020
Citation in opposition procedure - 024
Oct 27, 2020
Citation in opposition procedure - 025
Oct 27, 2020
Citation in opposition procedure - 026
Oct 27, 2020
Consolidated list of cited opposition documents
Oct 27, 2020
Letter accompanying subsequently filed items
Oct 27, 2020
Reply of the patent proprietor to the notice(s) of opposition
Jun 17, 2020
Communication of a notice of opposition and request to file observations
Jun 17, 2020
Notice of further oppositions to opponent(s)
May 28, 2020
Communication of a notice of opposition - first information to patent proprietor
May 20, 2020
(Electronic) Receipt
May 20, 2020
Citation in opposition procedure - 001
May 20, 2020
Citation in opposition procedure - 002
May 20, 2020
Citation in opposition procedure - 003
May 20, 2020
Citation in opposition procedure - 004
May 20, 2020
Citation in opposition procedure - 005
May 20, 2020
Citation in opposition procedure - 006
May 20, 2020
Citation in opposition procedure - 007
May 20, 2020
Citation in opposition procedure - 008
May 20, 2020
Citation in opposition procedure - 009
May 20, 2020
Citation in opposition procedure - 010
May 20, 2020
Citation in opposition procedure - 011
May 20, 2020
Citation in opposition procedure - 012
May 20, 2020
Citation in opposition procedure - 013
May 20, 2020
Citation in opposition procedure - 014
May 20, 2020
Citation in opposition procedure - 015
May 20, 2020
Citation in opposition procedure - 016
May 20, 2020
Citation in opposition procedure - 017
May 20, 2020
Citation in opposition procedure - 018
May 20, 2020
Citation in opposition procedure - 019
May 20, 2020
Citation in opposition procedure - 020
May 20, 2020
Citation in opposition procedure - 021
May 20, 2020
Citation in opposition procedure - 022
May 20, 2020
Notice of opposition
May 20, 2020
Notice of opposition
Sep 2, 2019
Transmission of the certificate for a European patent pursuant to Rule 74 EPC
Sep 2, 2019
Transmission of the certificate for a European patent pursuant to Rule 74 EPC
Jul 25, 2019
Decision to grant a European patent
Jun 3, 2019
(Electronic) Receipt
Jun 3, 2019
Letter accompanying subsequently filed items
Jun 3, 2019
Letter concerning the designation and/or extension and/or validation of states
Mar 28, 2019
(Electronic) Receipt
Mar 28, 2019
Filing of the translations of the claims
Mar 28, 2019
French translation of claims
Mar 28, 2019
German translation of the claims
Mar 28, 2019
Letter accompanying subsequently filed items
Feb 13, 2019
Bibliographic data of the European patent application
Feb 13, 2019
Communication about intention to grant a European patent
Feb 13, 2019
Intention to grant (signatures)
Feb 13, 2019
Text intended for grant (clean copy)
Feb 13, 2019
Text intended for grant (version for approval)
Jan 9, 2019
Examination started
Nov 28, 2018
(Electronic) Receipt
Nov 28, 2018
Letter accompanying subsequently filed items
Nov 28, 2018
Reply to invitation to file a copy of priority search results
Nov 26, 2018
Invitation to file a copy of search results(priority)
Nov 6, 2018
(Electronic) Receipt
Nov 6, 2018
Amended claims filed after receipt of (European) search report
Nov 6, 2018
Amended claims with annotations
Nov 6, 2018
Amended description filed after receipt of (European) search report
Nov 6, 2018
Amended description with annotations
Nov 6, 2018
Amendments received before examination
Nov 6, 2018
Letter accompanying subsequently filed items
Nov 6, 2018
Reminder period for payment of examination fee/designation fee and correction of deficiencies in Written Opinion/amendment
Oct 4, 2018
Notification of forthcoming publication
Oct 10, 2017
Communication regarding the transmission of the European search report
Oct 10, 2017
European search opinion
Oct 10, 2017
European search report
Oct 10, 2017
Information on Search Strategy
Sep 19, 2017
Letter concerning the priority
Sep 19, 2017
Priority document
Sep 18, 2017
Search started
Sep 6, 2017
Communication to designated inventor
Sep 6, 2017
Communication to designated inventor
Sep 6, 2017
Communication to designated inventor
Sep 6, 2017
Communication to designated inventor
Sep 6, 2017
Communication to designated inventor
Jul 14, 2017
Abstract
Jul 14, 2017
Acknowledgement of receipt of electronic submission of the request for grant of a European patent
Jul 14, 2017
Authorisation
Jul 14, 2017
Claims
Jul 14, 2017
Description
Jul 14, 2017
Designation of inventor
Jul 14, 2017
Request for grant of a European patent

EP3395331

ALFRED E TIEFENBACHER

Application Number: EP17181421A
Filing Date: Jul 14, 2017
Status: Revoked; Dec 3, 2021
Publication Date: Aug 21, 2019
External Links: Slate, Register , Google Patents

IP Verse

Pharmaceutical Tablet Composition Comprising Eltrombopag Olamine

Patent Summary

Patent Family

Patent Oppositions

Dossier Documents

EP3395331